Grand Medical Group AG is a Swiss-based health care company established in 2000 with a focused slogan - "The Path of Courage to Future Healthcare." Initially a health care marketing company, it has evolved into a manufacturer of pharmaceuticals, food supplements, and natural products targeting key therapeutic areas in Africa, Asia, and Europe. The company specializes in a wide range of pharmaceutical preparations including Anti-infective, Anti-osteoporosis, Central Nervous System, Cardiovascular, Immune-suppressants, Gastroenterology, Neurology, and Urology. Grand Medical Group AG operates through 3 pharmaceutical manufacturing facilities offering an array of products in Capsules, Tablets, and Intractable. Notably, it has recently commissioned a state-of-the-art manufacturing facility in Warsaw, Poland to cater to global demand. All their facilities hold approval from European Union Regulatory Authorities. The company actively exports its products to diverse markets across Asia, Africa, and Europe, with an impressive portfolio of over 75 products and 320 Marketing Authorizations within these regions. Overall, Grand Medical Group AG presents a compelling proposition within the health care and pharmaceutical industries, poised for expansion and potential investment opportunities.
There is no investment information
No recent news or press coverage available for Grand Medical Group AG.